128 related articles for article (PubMed ID: 23298488)
1. Clinicopathologic characteristics of YES-associated protein 1 overexpression and its relationship to tumor biomarkers in gastric cancer.
Zhang J; Yang YC; Zhu JS; Zhou Z; Chen WX
Int J Immunopathol Pharmacol; 2012; 25(4):977-87. PubMed ID: 23298488
[TBL] [Abstract][Full Text] [Related]
2. YES-associated protein 1 promotes adenocarcinoma growth and metastasis through activation of the receptor tyrosine kinase Axl.
Cui ZL; Han FF; Peng XH; Chen X; Luan CY; Han RC; Xu WG; Guo XJ
Int J Immunopathol Pharmacol; 2012; 25(4):989-1001. PubMed ID: 23298489
[TBL] [Abstract][Full Text] [Related]
3. Distinct prognostic values of YAP1 in gastric cancer.
Yu L; Gao C; Feng B; Wang L; Tian X; Wang H; Ma D
Tumour Biol; 2017 Apr; 39(4):1010428317695926. PubMed ID: 28381174
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of YAP1 is correlated with progression, metastasis and poor prognosis in patients with gastric carcinoma.
Hu X; Xin Y; Xiao Y; Zhao J
Pathol Oncol Res; 2014 Oct; 20(4):805-11. PubMed ID: 24643316
[TBL] [Abstract][Full Text] [Related]
5. Nuclear expression of Yes-associated protein 1 correlates with poor prognosis in intestinal type gastric cancer.
Song M; Cheong JH; Kim H; Noh SH; Kim H
Anticancer Res; 2012 Sep; 32(9):3827-34. PubMed ID: 22993325
[TBL] [Abstract][Full Text] [Related]
6. YAP1 enhances cell proliferation, migration, and invasion of gastric cancer in vitro and in vivo.
Sun D; Li X; He Y; Li W; Wang Y; Wang H; Jiang S; Xin Y
Oncotarget; 2016 Dec; 7(49):81062-81076. PubMed ID: 27835600
[TBL] [Abstract][Full Text] [Related]
7. miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis.
Kang W; Huang T; Zhou Y; Zhang J; Lung RWM; Tong JHM; Chan AWH; Zhang B; Wong CC; Wu F; Dong Y; Wang S; Yang W; Pan Y; Chak WP; Cheung AHK; Pang JCS; Yu J; Cheng ASL; To KF
Cell Death Dis; 2018 Jan; 9(2):92. PubMed ID: 29367737
[TBL] [Abstract][Full Text] [Related]
8. Low angiomotin-p130 with concomitant high Yes-associated protein 1 expression is associated with adverse prognosis of advanced gastric cancer.
Hong SA; Son MW; Cho J; Jang SH; Lee HJ; Lee JH; Cho HD; Oh MH; Lee MS
APMIS; 2017 Nov; 125(11):996-1006. PubMed ID: 28885730
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-506 inhibits gastric cancer proliferation and invasion by directly targeting Yap1.
Deng J; Lei W; Xiang X; Zhang L; Yu F; Chen J; Feng M; Xiong J
Tumour Biol; 2015 Sep; 36(9):6823-31. PubMed ID: 25846731
[TBL] [Abstract][Full Text] [Related]
10. High Yes-associated protein 1 with concomitant negative LATS1/2 expression is associated with poor prognosis of advanced gastric cancer.
Kim E; Ahn B; Oh H; Lee YJ; Lee JH; Lee Y; Kim CH; Chae YS; Kim JY
Pathology; 2019 Apr; 51(3):261-267. PubMed ID: 30819540
[TBL] [Abstract][Full Text] [Related]
11. YAP1-CPNE3 positive feedback pathway promotes gastric cancer cell progression.
Li X; Zhong H; Shi Q; Ruan R; Huang C; Wen Q; Zeng S; Xia Y; Zeng Q; Xiong J; Wang S; Chen J; Lei W; Deng J
Cell Mol Life Sci; 2024 Mar; 81(1):143. PubMed ID: 38493426
[TBL] [Abstract][Full Text] [Related]
12. MiR-375 and YAP1 expression profiling in medullary thyroid carcinoma and their correlation with clinical-pathological features and outcome.
Galuppini F; Bertazza L; Barollo S; Cavedon E; Rugge M; Guzzardo V; Sacchi D; Watutantrige-Fernando S; Vianello F; Mian C; Pennelli G
Virchows Arch; 2017 Nov; 471(5):651-658. PubMed ID: 28861609
[TBL] [Abstract][Full Text] [Related]
13. Expression of YES-associated protein (YAP) and its clinical significance in breast cancer tissues.
Cao L; Sun PL; Yao M; Jia M; Gao H
Hum Pathol; 2017 Oct; 68():166-174. PubMed ID: 28899737
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of Yes Associated Protein 1, an Independent Prognostic Marker in Patients With Pancreatic Ductal Adenocarcinoma, Correlated With Liver Metastasis and Poor Prognosis.
Salcedo Allende MT; Zeron-Medina J; Hernandez J; Macarulla T; Balsells J; Merino X; Allende H; Tabernero J; Ramon Y Cajal S
Pancreas; 2017 Aug; 46(7):913-920. PubMed ID: 28697132
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological significance of overexpression of TSPAN1, Ki67 and CD34 in gastric carcinoma.
Chen L; Li X; Wang GL; Wang Y; Zhu YY; Zhu J
Tumori; 2008; 94(4):531-8. PubMed ID: 18822690
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of the YAP1 oncogene in clear cell renal cell carcinoma is associated with poor outcome.
Rybarczyk A; Klacz J; Wronska A; Matuszewski M; Kmiec Z; Wierzbicki PM
Oncol Rep; 2017 Jul; 38(1):427-439. PubMed ID: 28504812
[TBL] [Abstract][Full Text] [Related]
17. Yes-associated protein 1 exhibits oncogenic property in gastric cancer and its nuclear accumulation associates with poor prognosis.
Kang W; Tong JH; Chan AW; Lee TL; Lung RW; Leung PP; So KK; Wu K; Fan D; Yu J; Sung JJ; To KF
Clin Cancer Res; 2011 Apr; 17(8):2130-9. PubMed ID: 21346147
[TBL] [Abstract][Full Text] [Related]
18. The significance of NTR1 expression and its correlation with β-catenin and EGFR in gastric cancer.
Zhou Z; Xie J; Cai Y; Yang S; Chen Y; Wu H
Diagn Pathol; 2015 Jul; 10():128. PubMed ID: 26215716
[TBL] [Abstract][Full Text] [Related]
19. Zinc finger protein 139 expression in gastric cancer and its clinical significance.
Li Y; Zhao Q; Fan LQ; Wang LL; Tan BB; Leng YL; Liu Y; Wang D
World J Gastroenterol; 2014 Dec; 20(48):18346-53. PubMed ID: 25561801
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of YAP1 in EGFR mutant lung adenocarcinoma prior to tyrosine kinase inhibitor therapy is associated with poor survival.
Hong SA; Jang SH; Oh MH; Kim SJ; Kang JH; Hong SH
Pathol Res Pract; 2018 Mar; 214(3):335-342. PubMed ID: 29487002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
